Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peg-interferon and Ribavirin for HCV in HIV Co-infected Patients
NCT02247440Phase 4Completed
- Sponsor
- Institut de Recherche pour le Développement
- Start
- Aug 2014
- Primary completion
- May 2017
- Modality
- Polymer-based Nanoparticles, Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2b, ribavirin in hepatitis C (HCV), sponsored by Institut de Recherche pour le Développement. Started Aug 2014; status: completed.
02
Drugs
peginterferon alfa-2bribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02247440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247440.